Norrby-Teglund A - Search Results

1

Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections.

Norrby-Teglund A, Ihendyane N, Darenberg J. Norrby-Teglund A, et al. Scand J Infect Dis. 2003;35(9):683-9. doi: 10.1080/00365540310015944. Scand J Infect Dis. 2003. PMID: 14620155 Review.

2

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections.

Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Norrby-Teglund A, et al. Scand J Infect Dis. 1995;27(2):125-30. doi: 10.3109/00365549509018991. Scand J Infect Dis. 1995. PMID: 7660074

3

Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease.

Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. Norrby-Teglund A, et al. J Infect Dis. 1994 Sep;170(3):585-91. doi: 10.1093/infdis/170.3.585. J Infect Dis. 1994. PMID: 8077715

4

Infections due to group A streptococcus: new concepts and potential treatment strategies.

Norrby SR, Norrby-Teglund A. Norrby SR, et al. Ann Acad Med Singap. 1997 Sep;26(5):691-3. Ann Acad Med Singap. 1997. PMID: 9494680 Review.

5

Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M. Chatellier S, et al. Infect Immun. 2000 Jun;68(6):3523-34. doi: 10.1128/IAI.68.6.3523-3534.2000. Infect Immun. 2000. PMID: 10816507 Free PMC article.

6

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, Talbot J, Low DE. Kaul R, et al. Clin Infect Dis. 1999 Apr;28(4):800-7. doi: 10.1086/515199. Clin Infect Dis. 1999. PMID: 10825042

7

Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.

Norrby-Teglund A, Ihendyane N, Kansal R, Basma H, Kotb M, Andersson J, Hammarström L. Norrby-Teglund A, et al. Clin Infect Dis. 2000 Nov;31(5):1175-82. doi: 10.1086/317423. Epub 2000 Nov 10. Clin Infect Dis. 2000. PMID: 11073749

8

Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection.

Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Norrby-Teglund A, et al. Eur J Immunol. 2000 Nov;30(11):3247-55. doi: 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D. Eur J Immunol. 2000. PMID: 11093140 Free article.

9

Evidence for superantigen involvement in severe group a streptococcal tissue infections.

Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE. Norrby-Teglund A, et al. J Infect Dis. 2001 Oct 1;184(7):853-60. doi: 10.1086/323443. Epub 2001 Aug 15. J Infect Dis. 2001. PMID: 11509997

10

Culture-negative severe septic shock: indications for streptococcal aetiology based on plasma antibodies and superantigenic activity.

Norrby-Teglund A, Berdal JE. Norrby-Teglund A, et al. Scand J Infect Dis. 2001;33(8):634-7. doi: 10.1080/00365540110026809. Scand J Infect Dis. 2001. PMID: 11525365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters